Less aggressive frontline treatment may be reasonable for primary gastrointestinal mantle cell lymphoma with lower disease burden Contributor Behind the paper Less aggressive frontline treatment may be reasonable for primary gastrointestinal mantle cell lymphoma with lower disease burden Aung Tun Jan 09, 2021
